Cytokinetics Inc vs Gigacloud Technology Inc — how do they compare? Cytokinetics Inc trades at $76.67 (market cap $10.63B), while Gigacloud Technology Inc trades at $51 (market cap $1.84B). The key difference: Cytokinetics Inc is far larger — about 5.8× Gigacloud Technology Inc's market cap, and Gigacloud Technology Inc is trading nearer its 52-week high, Cytokinetics Inc nearer its low. Which is the better fit depends on your goals.
| CYTK | GCT | |
|---|---|---|
Market Cap | $10.63B | $1.84B |
Sector | Technology | Technology |
52-Week High | $87.26 | $53.25 |
52-Week Low | $34.31 | $25.44 |
Enterprise Value | $10.74B | $1.97B |
Trailing returns across standard periods
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →Gigacloud Technology operates a global B2B e-commerce marketplace for large-parcel goods. It provides a comprehensive solution for furniture manufacturers and retailers with integrated logistics and fulfillment.
Read more on GCT →